RED MAMMOTH capsules, 400 mg, packaged in 10-count blisters per carton, ASIN B00KA8FBNI, barcode X001ANE0I5.
Published February 23, 2022 · Recall initiated: February 8, 2022
Summary
FDA records drug Class I recall D-0638-2022, published February 23, 2022 and initiated February 8, 2022. Recalling firm: Celebrate Today; Status: Terminated; Reported quantity: 500 cartons; Lot: Lot # DK1027, Exp. 08/01/2023. Class I means a reasonable probability of serious adverse health consequences or death.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Marketed Without An Approved NDA/ANDA: Product was found to contain undeclared sildenafil and tadalafil, ingredients found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug.
What to do
Voluntary: Firm initiated · Press Release
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Celebrate Today
- Distributor
- Product was distributed nationwide in the USA via Amazon Marketplace
- Lot
- Lot # DK1027, Exp. 08/01/2023
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAMorphine Sulfate PF 25 mg/25mL (1 mg/mL) in NaCl, 25 mL in 30 mL Single Dose Syringe, Rx only, STAQ Pharma,February 23, 2022
- FDAPARAGARD T380A (intrauterine copper contraceptive), 1 unit per carton together with an insertion tube andFebruary 23, 2022
- FDAHYDROmorphone HCl PF 10 mg/50 mL (0.2mg/mL) in NaCl, 50 mL in 50 mL Single Dose Syringe, Rx only, STAQ Pharma,February 23, 2022
- FDAHCG 6,000iu (lyo) Human Chorionic Gonadotropin Inj., For Sub-Q or IM Use Only, Not For IV Use, Vial, Rx Only,February 23, 2022
- FDA365 SKINNY High Intensity Capsules, 600 mg, 30-count bottle, BODY BALANCE INTERNACIONALFebruary 23, 2022
- FDAErythromycin Topical Gel USP, 2%, Net Wt 30 g tube, Rx only, Manufactured by: Teligent Pharma, Inc., Buena, NJFebruary 23, 2022
Questions about this recall
Was RED MAMMOTH capsules, 400 mg, packaged in 10-count blisters per carton, ASIN B00KA8FBNI, barcode X001ANE0I5. recalled?
Yes. FDA published recall D-0638-2022 on February 23, 2022. Reported hazard: Marketed Without An Approved NDA/ANDA: Product was found to contain undeclared sildenafil and tadalafil, ingredients found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug.
What should I do if I have this product?
Voluntary: Firm initiated · Press Release